Diffusion Pharmaceuticals Inc. (DFFN) NASDAQ
$6.60 - (-)
Market Cap: $13.47M
As of 08/16/23 12:00 AM EDT. Market closed.
Diffusion Pharmaceuticals Inc. (DFFN)
NASDAQ
$6.60
- (-)
Market Cap: $13.47M
As of 08/16/23 12:00 AM EDT. Market closed.
diffusion pharmaceuticals is a clinical stage company focused on improving the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors, without adding harmful side effects. the company is developing its lead drug, trans sodium crocetinate (tsc), which has received orphan drug designation from the fda for use in a number of cancers in which tumor ... read more
diffusion pharmaceuticals is a clinical stage company focused on improving the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors, without adding harmful side effects. the company is developing its lead drug, trans sodium crocetinate (tsc), which has received orphan drug designation from the fda for use in a number of cancers in which tumor hypoxia (oxygen deprivation) diminishes the efficacy of current treatments. tsc targets the cancer’s hypoxic micro-environment, re-oxygenating treatment-resistant tissue and making the cancerous cells more vulnerable to the therapeutic effects of conventional radiation and chemotherapy. the company is poised to begin a pivotal phase 3 trial in glioblastoma (gbm) in 2016. other programs include planned phase 2/3 trials in pancreatic cancer and brain metastases. because tsc’s novel mechanism safely re-oxygenates a wide range of tumor types, its use is not limited to a specific tumor tissue, but read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Cobuzzi Robert Joseph Jr. | President & CEO | Apr 18, 2022 | Option Exercise | $25.00 | 100 | 2,500 | 792 | Apr 19, 2022, 05:18 PM |
ELDER WILLIAM ROBERT | GC & Secretary | Apr 18, 2022 | Option Exercise | $25.00 | 100 | 2,500 | 400 | Apr 19, 2022, 05:17 PM |
Cobuzzi Robert Joseph Jr. | President & CEO | Nov 16, 2020 | Buy | $0.66 | 14,000 | 9,240 | 14,000 | Nov 18, 2020, 09:15 PM |
ELDER WILLIAM ROBERT | GC & Secretary | Nov 17, 2020 | Buy | $0.63 | 5,000 | 3,150 | 15,000 | Nov 18, 2020, 08:33 AM |
ELDER WILLIAM ROBERT | GC & Secretary | Nov 16, 2020 | Buy | $0.67 | 10,000 | 6,700 | 10,000 | Nov 18, 2020, 08:33 AM |
BARER SOL J | Chairman of the Board | Jun 06, 2014 | Option Exercise | $2.00 | 552,738 | 1,105,476 | 1,011,072 | Jun 19, 2014, 05:55 PM |
BARER SOL J | Chairman of the Board | Jun 06, 2014 | Option Exercise | $2.00 | 552,738 | 1,105,476 | 46,386,071 | Jun 10, 2014, 08:12 PM |
BLECH ISAAC | 10% Owner | May 29, 2013 | Option Exercise | $0.06 | 108,333,333 | 6,500,000 | 138,571,429 | Jun 10, 2013, 10:20 AM |
BLECH ISAAC | 10% Owner | May 29, 2013 | Option Exercise | $0.06 | 8,333,333 | 500,000 | 26,666,667 | Jun 10, 2013, 10:20 AM |
BLECH ISAAC | 10% Owner | May 02, 2013 | Buy | $0.06 | 18,333,334 | 1,100,000 | 18,333,334 | Jun 10, 2013, 10:20 AM |
Owner | Relationship | Date | Value($) |
Cobuzzi Robert Joseph Jr. | President & CEO | 04/18/2022 | 2,500 |
ELDER WILLIAM ROBERT | GC & Secretary | 04/18/2022 | 2,500 |
Cobuzzi Robert Joseph Jr. | President & CEO | 11/16/2020 | 9,240 |
ELDER WILLIAM ROBERT | GC & Secretary | 11/17/2020 | 3,150 |
ELDER WILLIAM ROBERT | GC & Secretary | 11/16/2020 | 6,700 |
BARER SOL J | Chairman of the Board | 06/06/2014 | 1,105,476 |
BARER SOL J | Chairman of the Board | 06/06/2014 | 1,105,476 |
BLECH ISAAC | 10% Owner | 05/29/2013 | 6,500,000 |
BLECH ISAAC | 10% Owner | 05/29/2013 | 500,000 |
BLECH ISAAC | 10% Owner | 05/02/2013 | 1,100,000 |
Period of Report: 06/30/2023
10-K/10-Q Filings: View